View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
HHS/FDA RIN: 0910-AA49 Publication ID: Spring 1999 
Title: Registration of Producers of Drugs and Listing of Drugs in Commercial Distribution 
Abstract: The proposed rule would revise the regulations under part 207 to clarify the burden on manufacturers, packers, and distributors and to consolidate, reorganize, and streamline the requirements. 
Agency: Department of Health and Human Services(HHS)  Priority: Other Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Long-Term Actions 
Major: Undetermined  Unfunded Mandates: Undetermined 
CFR Citation: 21 CFR 207   
Legal Authority: 21 USC 331    21 USC 351    21 USC 352    21 USC 355    21 USC 360    21 USC 371   
Timetable:
Action Date FR Cite
NPRM  To Be Determined    
Regulatory Flexibility Analysis Required: Undetermined  Government Levels Affected: Undetermined 
Included in the Regulatory Plan: No 
Agency Contact:
Lee D. Korb
Regulatory Counsel
Department of Health and Human Services
Food and Drug Administration
Suite 3037 (HFD-7), Center for Veterinary Medicine, 7519 Standish Place, Room 164, MPN-4, HFV-200,
Rockville, MD 20855
Phone:240 276-9258
Fax:240 276-7692
Email: lee.korb@fda.hhs.gov